| Literature DB >> 30227613 |
Zhao-Xia Li1, Xiu-Fang Wang2, Guang-Wei Ren3, Xiao-Long Yuan4, Ning Deng5, Gui-Xia Ji6, Wei Li7, Peng Zhang8.
Abstract
Considerable attention has been paid to marine derived endophytic fungi, owing to their capacity to produce novel secondary metabolites with potent bioactivities. In this study, two new compounds with a prenylated diphenyl ether structure-diorcinol L (1) and (R)-diorcinol B (2)-were isolated from the marine algal-derived endophytic fungus Aspergillus tennesseensis, along with seven known compounds: (S)-diorcinol B (3), 9-acetyldiorcinol B (4), diorcinol C (5), diorcinol D (6), diorcinol E (7), diorcinol J (8), and a dihydrobenzofuran derivative 9. Their structures were elucidated by extensive NMR spectroscopy studies. Compound 2 represents the first example of an R-configuration in the prenylated moiety. All these isolated compounds were examined for antimicrobial and cytotoxic activities. Compounds 1⁻9 exhibited antimicrobial activities against some human- and plant-pathogenic microbes with MIC values ranging from 2 to 64 μg/mL. Moreover, compound 9 displayed considerable inhibitory activity against the THP-1 cell line in vitro, with an IC50 value of 7.0 μg/mL.Entities:
Keywords: Aspergillus tennesseensis; antimicrobial activity; cytotoxicity; diphenyl ethers; marine-derived fungi; secondary metabolites
Mesh:
Substances:
Year: 2018 PMID: 30227613 PMCID: PMC6225247 DOI: 10.3390/molecules23092368
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structures of the isolated compounds 1–9 and the related compound awajanoran.
1H (500 MHz) and 13C-NMR (125 MHz) data of compounds 1 and 2 in DMSO-d6.
| Compound 1 | Compound 2 | |||
|---|---|---|---|---|
| No. | δH (mult, | δC, Type | δH (mult, | δC, Type |
| 1 | 154.8, C | 156.1, C | ||
| 2 | 121.0, C | 119.3, C | ||
| 3 | 139.1, C | 139.8, C | ||
| 4 | 6.39, d (2.1) | 113.5, CH | 6.37, d (2.2) | 113.1, CH |
| 5 | 156.5, C | 156.6, C | ||
| 6 | 6.10, d (2.1) | 104.8, CH | 6.08, d (2.2) | 104.1, CH |
| 7 | 2.13, s | 19.8, CH3 | 2.25, s | 20.5, CH3 |
| 8 | 3.17, d (7.0) | 25.6, CH2 | 3.05, dd (14.5, 2.0) 2.80, dd (14.5, 11.4) | 29.3, CH2 |
| 9 | 6.17, t (7.0) | 132.5, CH | 4.04, dd (11.4, 2.0) | 73.2, CH |
| 10 | 133.8, C | 72.1, C | ||
| 11 | 172.5, C | 1.19, s | 27.2, CH3 | |
| 12 | 1.73, s | 14.1, CH3 | 1.20, s | 26.2, CH3 |
| 1’ | 159.1, C | 158.9, C | ||
| 2’ | 6.26, br s | 111.0, CH | 6.30, br s | 111.2, CH |
| 3’ | 140.2, C | 140.4, C | ||
| 4’ | 6.11, br s | 109.0, CH | 6.20, br s | 109.9, CH |
| 5’ | 158.9, C | 158.4, C | ||
| 6’ | 6.08, br s | 102.3, CH | 6.10, br s | 102.7, CH |
| 7’ | 2.14, s | 21.6, CH3 | 2.16, s | 21.6, CH3 |
| 10-OH | 4.77, s | |||
Figure 2Key COSY (bold lines) and HMBC (arrows) correlations for compounds 1 and 2.
Minimum inhibitory concentration (MIC, μg/mL) of compounds 1–9 against human- and plant-pathogenic microbes.
| Compound | Bacteria a | Fungi b | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| B. s. | E. c. | P. a. | R. s. | A. a. | C. h. | G. g. | G. c. | M. h. | T. b. | |
| 1 | − c | 8 | 16 | 8 | 16 | 32 | 16 | 32 | − | − |
| 2 | 8 | 4 | 16 | 16 | 64 | 4 | 16 | 64 | 32 | 64 |
| 3 | − | − | 16 | 32 | − | − | 32 | 64 | 64 | 64 |
| 4 | 16 | 16 | 32 | 8 | − | − | 32 | − | 32 | 64 |
| 5 | 8 | − | 32 | − | − | − | − | 32 | 16 | − |
| 6 | 32 | 8 | 64 | − | − | − | 64 | 32 | − | − |
| 7 | 8 | 64 | − | 32 | − | − | 2 | − | 16 | − |
| 8 | 4 | − | 64 | 16 | − | − | − | − | 8 | − |
| 9 | 2 | 64 | 32 | − | − | − | − | 16 | 8 | 8 |
| Ch d | 0.5 | 2 | 16 | 16 | ||||||
| Pr e | 16 | 8 | 8 | 32 | 8 | 64 | ||||
a B. s., Bacillus subtilis; E. c., Escherichia coli; P. a., Pseudomonas aeruginosa; R. s., Ralstonia solanacearum; b A. a., Alternaria alternate; C. h., Cochliobolus heterostrophus; G. g., Gaeumannomyces graminis; G. c., Glomerella cingulata; M. h., Mucor hiemalis; T. b., Thielaviopsis basicola; c MIC > 64 μg/mL; d Ch, positive control, chloramphenicol; e Pr, positive control, prochloraz.